Immunotherapy of distant metastatic disease

Immunotherapy of metastatic melanoma consists of various approaches leading to specific or non-specific immunomodulation. The use of FDA-approved interleukin (IL)-2 alone, in combination with interferon α, and/or with various chemotherapeutic agents (biochemotherapy) is associated with significant t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schadendorf, D., Algarra, S. M., Bastholt, L., Cinat, G., Dreno, B., Eggermont, A. M. M., Espinosa, E., Guo, J., Hauschild, A., Petrella, T., Schachter, J., Hersey, P.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712591/
https://www.ncbi.nlm.nih.gov/pubmed/19617297
http://dx.doi.org/10.1093/annonc/mdp253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712591/
https://www.ncbi.nlm.nih.gov/pubmed/19617297
http://dx.doi.org/10.1093/annonc/mdp253

Ejemplares similares